Remove 2013 Remove Board-Certified Physicians Remove Clinic Remove Provider
article thumbnail

Rheumatology Board Meeting Summary | Spring 2025

ABIM

Dave, MD, MPH , inquired how stressors may contribute to candidates failing the certification examination and Dr. McDonald stated that knowledge gaps were the primary cause, though ABIM provides safeguards to reduce stress like grace periods and consideration of compassionate exemptions for extraordinary life circumstances.

article thumbnail

Hematology Board Meeting Summary | Spring 2025

ABIM

Diplomate Professional Profile* The Diplomate Professional Profile is a questionnaire built into the ABIM Physician Portal and required of all ABIM Board Certified physicians every five years. Advanced Practice Providers in the Hematology-Oncology Workforce* Guinevere Z.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Some members of the Specialty Board were interested in the LKA experience, participant survey results—particularly responses about fairness—and how LKA performance data might reflect on clinical outcomes. ABIM’s website features expansive sections on research related to assessment and clinical outcomes.

article thumbnail

Nephrology Board Meeting Summary | Spring 2025

ABIM

Diplomate Professional Profile* The Diplomate Professional Profile is a questionnaire built into the ABIM Physician Portal and required of all ABIM Board Certified physicians. Of note, the findings so far indicate that 90% of nephrologists who responded are clinically active.